Geomatys SAS

Arles / 24 rue Pierre Renaudel

Emerging infectious diseases are a key threat to lives and livelihoods worldwide, but the information governments and industries need to prepare for them is not widely accessible. Because diseases are heavily influenced by changes in the environment, Geomatys offers a State-of-the-Art infectious disease forecasting that brings together the most up-to-date knowledge of top domain experts and the most sophisticated geospatial big-data, earth observation, and behavioral AI analytics technology to respond to an estimated $50 billion global market. We offer risk stratification projections and a decision-making platform for in-house integration and analysis of proprietary data for important emerging infectious diseases (Ebola, dengue, Chagas, etc.). In tight collaboration with global disease researchers and public health authorities, we provide timely, reliable information capable of preparing stakeholders to respond to public health risks in a rapidly changing world.

Business axis :

E-health

Category : TPE
Legal form : SAS
Number of employees : 20
Website :
Turnover :

921.00 K€